433 related articles for article (PubMed ID: 2578513)
21. Macrophage activation factor from EL-4, a murine T-cell line: antigenic characterization by hamster monoclonal antibodies to murine interferon-gamma.
Meltzer MS; Gilbreath MJ; Crawford RM; Schreiber RD; Nacy CA
Cell Immunol; 1987 Jul; 107(2):340-7. PubMed ID: 3109744
[TBL] [Abstract][Full Text] [Related]
22. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
[TBL] [Abstract][Full Text] [Related]
23. Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma.
Margolick JB; Ambrus JL; Volkman DJ; Fauci AS
J Immunol; 1986 Jan; 136(2):546-54. PubMed ID: 2416812
[TBL] [Abstract][Full Text] [Related]
24. Obligatory role of gamma interferon in T cell-replacing factor-dependent, antigen-specific murine B cell responses.
Brunswick M; Lake P
J Exp Med; 1985 May; 161(5):953-71. PubMed ID: 2580939
[TBL] [Abstract][Full Text] [Related]
25. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG
Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737
[TBL] [Abstract][Full Text] [Related]
26. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
Murray HW; Rubin BY; Carriero S; Acosta AM
J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909
[TBL] [Abstract][Full Text] [Related]
27. Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.
Svedersky LP; Benton CV; Berger WH; Rinderknecht E; Harkins RN; Palladino MA
J Exp Med; 1984 Mar; 159(3):812-27. PubMed ID: 6421982
[TBL] [Abstract][Full Text] [Related]
28. Lymphokine-mediated induction of antigen-presenting ability in thymic stromal cells.
Ransom J; Fischer M; Mercer L; Zlotnik A
J Immunol; 1987 Oct; 139(8):2620-8. PubMed ID: 3116089
[TBL] [Abstract][Full Text] [Related]
29. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
30. Distinct functional domains on the recombinant human immune interferon molecule.
Ziai MR; Imberti L; Kobayashi M; Perussia B; Trinchieri G; Ferrone S
Cancer Res; 1986 Dec; 46(12 Pt 1):6187-90. PubMed ID: 3096556
[TBL] [Abstract][Full Text] [Related]
31. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
James SL; Lazdins JK; Hieny S; Natovitz P
J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.
Wong GH; Clark-Lewis I; McKimm-Breschkin L; Harris AW; Schrader JW
J Immunol; 1983 Aug; 131(2):788-93. PubMed ID: 6408189
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of monoclonal antibodies directed to rat interferon-gamma.
van der Meide PH; Borman AH; Beljaars HG; Dubbeld MA; Botman CA; Schellekens H
Lymphokine Res; 1989; 8(4):439-49. PubMed ID: 2478843
[TBL] [Abstract][Full Text] [Related]
34. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
Thurman GB; Braude IA; Gray PW; Oldham RK; Stevenson HC
J Immunol; 1985 Jan; 134(1):305-9. PubMed ID: 3917277
[TBL] [Abstract][Full Text] [Related]
35. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
[TBL] [Abstract][Full Text] [Related]
36. Secretion of a macrophage-activating factor distinct from interferon-gamma by human T cell clones.
Andrew PW; Rees AD; Scoging A; Dobson N; Matthews R; Whittall JT; Coates AR; Lowrie DB
Eur J Immunol; 1984 Oct; 14(10):962-4. PubMed ID: 6436035
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody which has the neutralizing activities for human IL-2.
Sato H; Natsuume-Sakai S; Miyawaki T; Taga K; Hatano M; Taniguchi N
J Biol Response Mod; 1986 Apr; 5(2):191-201. PubMed ID: 3488373
[TBL] [Abstract][Full Text] [Related]
38. Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine?
Zlotnik A; Roberts WK; Vasil A; Blumenthal E; Larosa F; Leibson HJ; Endres RO; Graham SD; White J; Hill J; Henson P; Klein JR; Bevan MJ; Marrack P; Kappler JW
J Immunol; 1983 Aug; 131(2):794-800. PubMed ID: 6223094
[TBL] [Abstract][Full Text] [Related]
39. A T cell-independent mechanism of macrophage activation by interferon-gamma.
Bancroft GJ; Schreiber RD; Bosma GC; Bosma MJ; Unanue ER
J Immunol; 1987 Aug; 139(4):1104-7. PubMed ID: 3112223
[TBL] [Abstract][Full Text] [Related]
40. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
Zlotnik A; Fischer M; Roehm N; Zipori D
J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]